Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 11.73B | 12.30B | 10.37B | 7.83B | 7.14B | 6.45B |
Gross Profit | 3.48B | 3.40B | 3.32B | 2.56B | 2.28B | 1.92B |
EBITDA | 1.27B | 1.35B | 2.39B | 2.14B | 2.18B | 1.37B |
Net Income | -323.22M | -682.43M | 585.35M | 672.52M | -385.79M | 98.64M |
Balance Sheet | ||||||
Total Assets | 16.90B | 26.99B | 25.53B | 9.81B | 10.37B | 9.64B |
Cash, Cash Equivalents and Short-Term Investments | 4.00B | 14.07B | 13.17B | 2.86B | 3.42B | 2.17B |
Total Debt | 1.65B | 1.64B | 1.73B | 8.12M | 515.16M | 1.03B |
Total Liabilities | 6.58B | 16.86B | 14.70B | 4.85B | 4.61B | 2.33B |
Stockholders Equity | 10.33B | 10.13B | 10.83B | 4.96B | 5.77B | 7.31B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 1.11B | -2.40B | 1.43B | 765.44M | -1.27B |
Operating Cash Flow | 0.00 | 3.62B | 533.23M | 2.80B | 2.11B | 1.04B |
Investing Cash Flow | 0.00 | -2.64B | 4.59B | -1.38B | -1.34B | -2.31B |
Financing Cash Flow | 0.00 | -83.28M | 5.19B | -1.98B | 485.94M | 905.50M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
72 Outperform | ¥20.20B | 14.85 | 2.77% | 20.61% | 15.24% | ||
70 Outperform | ¥2.95B | 31.80 | 1.83% | 9.70% | -38.92% | ||
69 Neutral | ¥58.21B | 43.71 | ― | 10.47% | ― | ||
66 Neutral | ¥102.88B | 12.86 | 5.05% | 23.09% | 27.56% | ||
65 Neutral | ¥18.20B | 220.60 | ― | 18.62% | -216.40% | ||
63 Neutral | $33.26B | 5.86 | -11.55% | 1.91% | 5.52% | -20.13% | |
56 Neutral | ¥15.73B | 93.67 | ― | ― | ― |